Close

Geron (GERN) Reports Partical FDA Clinical Hold on Imetelstat in Myelofibrosis IST

March 20, 2014 7:33 AM EDT Send to a Friend
Geron Corporation (Nasdaq: GERN) announced that patients currently enrolled in the investigator-sponsored clinical trial of imetelstat in myelofibrosis (Myelofibrosis IST) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login